| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |